188 related articles for article (PubMed ID: 24959040)
1. Biomarkers and chemopreventives in oral carcinogenesis and its prevention.
Shah S; Kaur M
J Oral Maxillofac Pathol; 2014 Jan; 18(1):69-76. PubMed ID: 24959040
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers and molecular epidemiology and chemoprevention of oral carcinogenesis.
Schwartz JL
Crit Rev Oral Biol Med; 2000; 11(1):92-122. PubMed ID: 10682902
[TBL] [Abstract][Full Text] [Related]
3. Strategies for phase II cancer chemoprevention trials: cervix, endometrium, and ovary.
Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Steele VE; Lubet RA; Sigman CC
J Cell Biochem Suppl; 1995; 23():1-9. PubMed ID: 8747372
[TBL] [Abstract][Full Text] [Related]
4. Development of chemopreventive agents for lung and upper aerodigestive tract cancers.
Kelloff GJ; Boone CW; Steele VK; Perloff M; Crowell J; Doody LA
J Cell Biochem Suppl; 1993; 17F():2-17. PubMed ID: 8412195
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention trials and surrogate end point biomarkers in the cervix.
Mitchell MF; Hittelman WK; Lotan R; Nishioka K; Tortolero-Luna G; Richards-Kortum R; Wharton JT; Hong WK
Cancer; 1995 Nov; 76(10 Suppl):1956-77. PubMed ID: 8634987
[TBL] [Abstract][Full Text] [Related]
6. Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype.
Mallery SR; Wang D; Santiago B; Pei P; Schwendeman SP; Nieto K; Spinney R; Tong M; Koutras G; Han B; Holpuch A; Lang J
Cancer Prev Res (Phila); 2017 Jan; 10(1):76-88. PubMed ID: 27756753
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. 4-nitroquinoline-1-oxide induced experimental oral carcinogenesis.
Kanojia D; Vaidya MM
Oral Oncol; 2006 Aug; 42(7):655-67. PubMed ID: 16448841
[TBL] [Abstract][Full Text] [Related]
9. In vitro growth changes of oral human keratinocytes after treatment with carotenoids, retinoid, and/or DMBA.
Schwartz JL
Nutr Cancer; 1999; 33(1):58-68. PubMed ID: 10227045
[TBL] [Abstract][Full Text] [Related]
10. Alterations in keratins and associated proteins during 4- Nitroquinoline-1-oxide induced rat oral carcinogenesis.
Kanojia D; Sawant SS; Borges AM; Ingle AD; Vaidya MM
J Carcinog; 2012; 11():14. PubMed ID: 23233820
[TBL] [Abstract][Full Text] [Related]
11. Cancer Chemoprevention: A Strategic Approach Using Phytochemicals.
G MS; Swetha M; Keerthana CK; Rayginia TP; Anto RJ
Front Pharmacol; 2021; 12():809308. PubMed ID: 35095521
[TBL] [Abstract][Full Text] [Related]
12. Progress in Drug and Formulation Development for the Chemoprevention of Oral Squamous Cell Carcinoma: A Review.
Sarma H; Jahan T; Sharma HK
Recent Pat Drug Deliv Formul; 2019; 13(1):16-36. PubMed ID: 30806332
[TBL] [Abstract][Full Text] [Related]
13. The Hamster Model of Sequential Oral Carcinogenesis: An Update.
Yapijakis C; Kalogera S; Papakosta V; Vassiliou S
In Vivo; 2019; 33(6):1751-1755. PubMed ID: 31662499
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of heat shock protein 70 in oral carcinogenesis and prediction of progression and recurrence in oral squamous cell carcinoma patients: a retrospective clinicopathological study.
Elhendawy HA
Eur J Med Res; 2023 Oct; 28(1):464. PubMed ID: 37884988
[TBL] [Abstract][Full Text] [Related]
15. Genetic and Epigenetic Biomarkers of Molecular Alterations in Oral Carcinogenesis.
Dumache R; Rogobete AF; Andreescu N; Puiu M
Clin Lab; 2015; 61(10):1373-81. PubMed ID: 26642697
[TBL] [Abstract][Full Text] [Related]
16. The evolution of predictive oncology and molecular-based therapy for oral cancer prevention.
Sudbø J; Reith A
Int J Cancer; 2005 Jun; 115(3):339-45. PubMed ID: 15688375
[TBL] [Abstract][Full Text] [Related]
17. Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance.
Albanes D; Heinonen OP; Taylor PR; Virtamo J; Edwards BK; Rautalahti M; Hartman AM; Palmgren J; Freedman LS; Haapakoski J; Barrett MJ; Pietinen P; Malila N; Tala E; Liippo K; Salomaa ER; Tangrea JA; Teppo L; Askin FB; Taskinen E; Erozan Y; Greenwald P; Huttunen JK
J Natl Cancer Inst; 1996 Nov; 88(21):1560-70. PubMed ID: 8901854
[TBL] [Abstract][Full Text] [Related]
18. Chemoprevention: general perspective.
Shureiqi I; Reddy P; Brenner DE
Crit Rev Oncol Hematol; 2000 Mar; 33(3):157-67. PubMed ID: 10789490
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of supplemental beta-carotene to prevent second head and neck cancer.
Mayne ST; Cartmel B; Baum M; Shor-Posner G; Fallon BG; Briskin K; Bean J; Zheng T; Cooper D; Friedman C; Goodwin WJ
Cancer Res; 2001 Feb; 61(4):1457-63. PubMed ID: 11245451
[TBL] [Abstract][Full Text] [Related]
20. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.
Grimm M; Hoefert S; Krimmel M; Biegner T; Feyen O; Teriete P; Reinert S
Oral Maxillofac Surg; 2016 Sep; 20(3):295-302. PubMed ID: 26875085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
